Centerra Gold (CGAU) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

07.08.25 02:00 Uhr

Werte in diesem Artikel
Rohstoffe

3.762,71 USD 0,00 USD 0,00%

Centerra Gold Inc. (CGAU) reported $288.34 million in revenue for the quarter ended June 2025, representing a year-over-year increase of 2.1%. EPS of $0.25 for the same period compares to $0.23 a year ago.The reported revenue represents no surprise over the Zacks Consensus Estimate of $0 million. With the consensus EPS estimate being $0.17, the EPS surprise was +47.06%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.Here is how Centerra Gold performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:Gold produced: 63.31 Koz compared to the 63.27 Koz average estimate based on three analysts.Gold production costs: $1308 per ounce versus $1129 per ounce estimated by three analysts on average.All-in sustaining costs on a by-product basis: $1652 per ounce compared to the $1777.7 per ounce average estimate based on three analysts.View all Key Company Metrics for Centerra Gold here>>>Shares of Centerra Gold have returned +3.4% over the past month versus the Zacks S&P 500 composite's +0.5% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.Zacks' Research Chief Picks Stock Most Likely to "At Least Double"Our experts have revealed their Top 5 recommendations with money-doubling potential – and Director of Research Sheraz Mian believes one is superior to the others. Of course, all our picks aren’t winners but this one could far surpass earlier recommendations like Hims & Hers Health, which shot up +209%.See Our Top Stock to Double (Plus 4 Runners Up) >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Centerra Gold Inc. (CGAU): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

Quelle: Zacks

Nachrichten zu Goldpreis